COM:89BIO
89Bio
- Stock
Last Close
8.38
22/11 21:00
Market Cap
851.02M
Beta: -
Volume Today
477.49K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
average inventory | |||||||
average payables | 1.25M - | 1.53M 22.26% | 4.45M 191.68% | 9.67M 117.16% | 10.54M 9.00% | ||
average receivables | |||||||
book value per share | -3.50 - | 38.37 1,195.29% | 12.62 67.12% | 6.27 50.32% | 4.36 30.39% | 0.01 99.83% | |
capex per share | -0.01 - | -0.06 596.90% | -0.01 86.79% | -0.00 59.98% | -0.00 93.58% | -0.00 99.97% | |
capex to depreciation | -6.50 - | -8.18 25.79% | -2.10 74.32% | -0.80 62.03% | -0.11 86.50% | 0.00 100.60% | |
capex to operating cash flow | 0.00 - | 0.01 74.55% | 0.00 50.09% | 0.00 69.89% | 0.00 89.48% | 0.00 64.13% | |
capex to revenue | |||||||
cash per share | 2.45 - | 39.83 1,524.98% | 19.34 51.44% | 12.39 35.92% | 5.41 56.37% | 0.01 99.85% | |
days of inventory on hand | |||||||
days payables outstanding | |||||||
days sales outstanding | |||||||
debt to assets | 0.12 - | 0.10 14.73% | 0.00 96.19% | ||||
debt to equity | 0.15 - | 0.13 14.27% | 0.00 96.73% | ||||
dividend yield | |||||||
earnings yield | -0.17 - | -0.93 449.15% | -0.13 86.45% | -0.34 171.74% | -0.23 32.88% | -0.00 99.92% | |
enterprise value | 84.11M - | -31.73M 137.73% | 187.41M 690.60% | 131.34M 29.92% | 407.87M 210.55% | 794.69B 194,736.03% | |
enterprise value over ebitda | -5.55 - | 1.19 121.46% | -3.80 418.79% | -1.46 61.46% | -3.99 172.57% | -5.26K 131,654.38% | |
ev to operating cash flow | -6.75 - | 1.25 118.48% | -4.05 425.16% | -1.71 57.79% | -5.03 194.05% | -6.15K 122,198.50% | |
ev to sales | |||||||
free cash flow per share | -2.73 - | -10.92 300.18% | -2.88 73.61% | -3.82 32.65% | -2.33 39.06% | -0.00 99.92% | |
free cash flow yield | -0.13 - | -0.42 216.61% | -0.12 71.53% | -0.29 147.34% | -0.18 37.43% | -0.00 99.91% | |
graham net net | -3.53 - | 37.43 1,159.68% | 18.83 49.69% | 10.58 43.84% | 4.11 61.11% | 0.01 99.82% | |
graham number | 16.68 - | 145.42 771.91% | 29.55 79.68% | 25.15 14.91% | 16.96 32.55% | 0.02 99.89% | |
income quality | 0.77 - | 0.44 42.48% | 0.93 110.70% | 0.85 8.81% | 0.79 6.71% | 0.91 14.31% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 53.20 - | 31.54 40.71% | |||||
interest debt per share | 0.97 - | 0.63 34.61% | -0.00 100.01% | ||||
inventory turnover | |||||||
invested capital | 0.15 - | 0.13 14.27% | 0.00 96.73% | ||||
market cap | 95.34M - | 61.63M 35.36% | 392.06M 536.16% | 262.69M 33.00% | 443.08M 68.68% | 795.00B 179,324.10% | |
net current asset value | -16.11M - | 89.72M 656.90% | 202.09M 125.25% | 125.52M 37.89% | 151.09M 20.37% | 533.57M 253.15% | |
net debt to ebitda | 0.74 - | 3.50 372.80% | 4.15 18.32% | 1.46 64.70% | 0.34 76.47% | 2.08 502.77% | |
net income per share | -3.53 - | -24.49 594.09% | -3.08 87.44% | -4.48 45.74% | -2.93 34.63% | -0.00 99.93% | |
operating cash flow per share | -2.72 - | -10.86 299.25% | -2.87 73.53% | -3.82 32.90% | -2.33 39.02% | -0.00 99.92% | |
payables turnover | |||||||
receivables turnover | |||||||
research and ddevelopement to revenue | |||||||
return on tangible assets | -1.42 - | -0.60 57.77% | -0.23 60.98% | -0.55 136.61% | -0.52 6.58% | -0.24 54.00% | |
revenue per share | |||||||
roe | 1.01 - | -0.64 163.37% | -0.24 61.80% | -0.72 193.38% | -0.67 6.08% | -0.27 60.54% | |
roic | 0.95 - | -0.30 131.43% | -0.24 18.31% | -0.62 153.78% | 0.59 196.33% | -0.27 145.76% | |
sales general and administrative to revenue | |||||||
shareholders equity per share | -3.50 - | 38.37 1,195.29% | 12.62 67.12% | 6.27 50.32% | 4.36 30.39% | 0.01 99.83% | |
stock based compensation to revenue | |||||||
tangible asset value | -16.06M - | 89.94M 660.15% | 202.96M 125.65% | 125.96M 37.94% | 151.83M 20.54% | 536.31M 253.22% | |
tangible book value per share | -3.50 - | 38.37 1,195.29% | 12.62 67.12% | 6.27 50.32% | 4.36 30.39% | 0.01 99.83% | |
working capital | 6.96M - | 89.72M 1,188.48% | 202.09M 125.25% | 142.44M 29.51% | 171.47M 20.37% | 563.92M 228.88% |
All numbers in USD (except ratios and percentages)